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Abstract: The widespread epidemic of obesity and type 2 diabetes (T2D), suggests that both disorders
are closely linked. Several pre-clinical and clinical studies have showed that adipose-derived
mesenchymal stem cells (ASC) transplantation is efficient and safe. Moreover, scientists have already
highlighted the therapeutic capacity of their secretomes. In this study, we used quantitative PCR, a
flow cytometry-based system, the ELISA method, spectrophotometry, and confocal and scanning
electron microscopy, to compare the differences in proliferation activity, viability, morphology,
mitochondrial dynamics, mRNA and miRNA expression, as well as the secretory activity of ASCs
derived from two donor groups—non-diabetic and T2D patients. We demonstrated that ASCs from
T2D patients showed a reduced viability and a proliferative potential. Moreover, they exhibited
mitochondrial dysfunction and senescence phenotype, due to excessive oxidative stress. Significant
differences were observed in the expressions of miRNA involved in cell proliferations (miR-16-5p,
miR-146a-5p, and miR-145-5p), as well as miRNA and genes responsible for glucose homeostasis and
insulin sensitivity (miR-24-3p, 140-3p, miR-17-5p, SIRT1, HIF-1α, LIN28, FOXO1, and TGFβ). We
have observed a similar correlation of miR-16-5p, miR-146a-5p, miR-24-3p, 140-3p, miR-17-5p, and
miR-145-5p expression in extracellular vesicles fraction. Furthermore, we have shown that ASCT2D
exhibited a lower VEGF, adiponectin, and CXCL-12 secretion, but showed an overproduction of
leptin. We have shown that type 2 diabetes attenuated crucial functions of ASC, like proliferation,
viability, and secretory activity, which highly reduced their therapeutic efficiency.
Keywords: adipose-derived mesenchymal stem cells; type 2 diabetes; extracellular microvesicle;
insulin resistance; regenerative medicine
1. Introduction
Over the last decade, type 2 diabetes (T2D) which is recognized as a progressive metabolic
disorder, has attained a status of global pandemic, especially in well-developed countries, all over
the world. A recent issue of the World Health Organization (WHO) Bulletin reported that 8.5% of
the global population suffer from diabetes, and according to the National Institute of Health (NIH),
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95% of cases in adult patients are T2D [1,2]. These estimates are also steadily growing. The most
significant modifiable risk factor for T2D is severe obesity, thus, a better understanding of the role of
adipose tissue in T2D development, is strongly required. A growing body of research has evidenced
that dysfunctional adipose tissues, mainly observed during obesity, are characterized by impaired
insulin signaling, insulin resistance, adipocyte hypertrophy, and macrophage infiltration [3]. T2D
is a leading cause of cardiovascular diseases, lower limb amputations, kidneys failure, as well as
retinopathy, which can directly result in blindness [2].
Adipose tissue becomes an easily accessible source of the unique population of adipose
tissue-derived mesenchymal stem cells (ASCs), characterized by their fibroblast-like morphology,
colony forming properties [4], capacity for self-renewal and a considerable proliferative rate, resulting
in the overexpression of Ki-67, which is widely used as a proliferation marker in clinics [5]. Moreover,
they possess a unique ability to differentiate into mesenchymal lineage cells, such as chondrocytes,
osteoblasts, and adipocytes, under proper conditions, which makes them an attractive tool for tissue
engineering and regenerative medical applications [6]. The isolation of ASCs from subcutaneous
adipose tissue is considered to be a relatively easy procedure, providing a high quantity of mesenchymal
stem cells (MSCs), compared to the inter alia bone-marrow-derived stem cells. Unfortunately, many
stem cell properties can be sorely influenced by some factors, such as ageing and metabolic disorders.
Several studies have shown, that MSCs isolated from aged individuals exhibit a reduced proliferative
activity and osteogenic potential, as well as senescent features, resulting in more senescence-associated
β-galactosidase-positive cells, leading to a decreased cell viability, in comparison to young donors [7].
Moreover, ASCs have been shown to exhibit immunomodulatory properties, which make them
promising therapeutic agents, since T2D is linked to chronic inflammation [8,9]. While increasing
evidence has shown that the unique properties of ASCs are explained by their ability to synthesize
and secrete a broad range of different growth factors, including inter alia, bone morphogenetic
protein 2 and 4 (BMP 2 and 4), leptin, adiponectin, stromal cell-derived factor -1α (SDF-1α), and the
vascular endothelial growth factor (VEGF), extracellular microvesicles (MVs) released by ASCs have
gained more interest for their paracrine communication capacity in the field of ASC transplantation
therapy [10–12]
Moreover, MVs have been observed to carry and release not only proteins but also nucleic acids,
like mRNAs and non-coding small regulatory RNAs, in particular microRNAs (miRNA), which have
the ability to cause pleiotropic effects on target cells [13]. miRNA, including miR-17-5p, miR-24-3p, and
miR-145-5p, play a substantial role in the pathogenesis of diabetes mellitus affecting the functioning
of the β-cell, and proliferative activity, insulin resistance, and glucose homeostasis, mainly through
the Phosphoinositide 3-Kinase (PI3K)/AKT Serine/Threonine Kinase (AKT) pathway [14,15]. Recent
studies have shown that multiple signaling pathways, including Wnt, BMP, FGF, and in particular
miRNAs, which are involved in the pro-regenerative capacity of ASCs, are seriously altered in diabetic
patients [16,17].
Excessive oxidative stress has been proposed as one of the major factor leading to insulin
resistance, impairment of glucose tolerance, and β-cell dysfunction [18,19]. Overproduction of
reactive oxygen species (ROS), such as superoxide (O–2-, nitric oxide (NO), and hydrogen peroxidase
(H2O2), with a simultaneous reduction of antioxidant defenses from the superoxide dismutase activity
(SOD), alters the cellular homeostasis and induces apoptosis [19]. The prolonged generation and
accumulation of ROS or NO might affect many cellular dysfunctions, including the induction of a
senescence character in the ASCs, a decreased ability to synthesize, secretion of particular growth
factors, loss of immunomodulatory effects, and finally result in cell death through the necrotic or
apoptotic mechanisms [20,21]. The most important sources of ROS production are the mitochondrial
electron-transport system, NAPDH oxidase, and the cytochrome P450 [21]. Moreover, apart from the
altered energy and overproduction of ROS, mitochondrial dysfunction is highly linked to an impaired
cellular calcium (Ca2+) homeostasis, which causes ER stress, and leads to the activation of a signaling
network called unfolded protein response (UPR) [22,23]. To maintain their health, the mitochondria
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undergo coordinated cycles of fusion (the joining of two organelles into one) and fission (the division of
one mitochondrion into two daughter mitochondria). Moreover, mitochondrial movements through the
cytoskeleton and mitophagy (targeted destruction via autophagy) have also been observed [24]. Several
studies have shown that insulin resistance leads to an imbalance in the mitochondrial fission/fusion
ratio, manifested by a higher fission activity, leading to an inefficient mitochondrial network [25]. In
other words, the metabolic disorders impair the subsequent modification of mitochondrial dynamics,
resulting in mitochondrial dysfunction.
According to the latest data, ASCs from aged donors [26,27], as well as from individuals suffering
from metabolic disorders [28–30] showed a diminished regenerative potential. In the present study,
we used a human model for type 2 diabetes, the most common form of diabetes that is frequently
associated with obesity and metabolic alterations in adipose tissue. We examined the effect of diabetes
on the morphology, proliferative activity, and viability of ASCs isolated from subcutaneous adipose
tissue. Moreover, we focused on the cellular senescence, the impairment of anti-oxidative defenses,
mitochondrial dynamics deterioration, the miRNA expression profile, and secretory activity. We
believe that this approach might offer a worthwhile path to explain the effect of type 2 diabetes on the
regenerative potential of ASCs.
2. Experimental Section
All reagents used in the study were purchased from Sigma-Aldrich (St. Louis, MO, USA), unless
otherwise stated.
The study was approved by the independent ethics committee of the Jagiellonian University,
Krakow, Poland (1072.6120.220.2018). Informed consent for the surgical treatment was obtained from
all patients, before the procedure.
2.1. Isolation and Culture of Human Adipose-Derived Mesenchymal Stem Cells (hASCs)
Human adipose-derived mesenchymal stem cells were isolated from subcutaneous adipose tissues
(AT), from non-diabetic (ASCCTRL) donors (both sexes, age 38–56; BMI = 15.45 ± 2.21; n = 6) or patients
with clinically confirmed type 2 diabetes (ASCT2D) (both sexes, age 36–69; BMI = 41.50 ± 5.50; n = 6)
with no history of smoking.
Human AT was collected during the surgical procedure of total hip arthroplasty. Immediately
after the tissue collection, the specimens were transferred to a tissue-transport medium, consisting
of Hank’s Balanced Salt Solution (HBSS), supplemented with 1% antibiotic–antimycotic solution
(Penicillin/Streptomycin/Amphotericin B, P/S/A). Immediately upon arrival, the adipose tissue
pieces were washed with phosphate-buffered saline (PBS), supplemented with 1% P/S, mechanically
disintegrated, and treated with 1 mg/mL solution of type I collagenase, at 37 ◦C, for 40 min. After
incubation, the digested tissue was centrifuged (1200× g, 10 min) to obtain a cell pellet. Then, the
supernatant was discarded and the cell pellet was resuspended in PBS, and centrifuged again (300× g,
4 min). After the second centrifugation, cells were seeded in a T25 cm2 polystyrene culture flask, and
cultured in Dulbecco’s Modified Eagle Medium (DMEM), with nutrient F-12 Ham supplemented with
10% of Fetal Bovine Serum (FBS), 1% Penicillin/Streptomycin/Amphotericin B (P/S/A) and 0.5% of
Gentamicin, upon reaching approximately 85% confluence. Then, the cells were gently recovered using
TrypLE Express solution (Life Technologies, Carlsbad, CA, USA) and re-seeded in a T75 cm2 flask. The
medium was renewed every 2–3 days. The cells were passaged, three times, prior to the experiment.
2.2. Proliferation Rate Assay
Cell proliferative activity was determined in two ways—using the reazurin-based assay kit (TOX
-8) for population doubling-time (PDT) evaluation, and with the BrdU Cell Proliferation ELISA Kit
(Abcam, Cambridge, UK). For the assessment of the PDT value, thrice passaged ASCs were seeded
onto 24-well plates, at a density of 2 × 104 cells per well. After, 24, 48, 72, and 96 h of culture, media
were replaced with a 10% resazurin dye solution, prepared in a fresh complete culture medium. After
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2 h of incubation at 37 ◦C in a CO2 incubator, the supernatants were subsequently transferred to
a 96-well plate and the absorbance levels were measured, spectrophotometrically (Epoch, Biotek,
Bad Friedrichshall, Germany), with the wavelengths of 600 nm and 690 nm as the reference length.
The PDT value was calculated with the support of online software [31].
For the cell proliferative activity determination using the BrdU Cell Proliferation ELISA Kit, the
cells were seeded onto 96-well plates, at a density of 6 × 103 cell/well in 100 µL of culture media.
The procedure was performed following the instructions provided by the supplier. After 24 h, 20 µL
of the diluted BrdU reagent was added directly to the culture medium and incubated for 18 h, at
37 ◦C, in standard growth conditions. Then, the cells were fixed, permeabilized, and incubated with
anti-BrdU monoclonal antibody detector. After 1 h of incubation, horseradish peroxidase-conjugated
goat anti-mouse antibody was added (incubation—30 min, RT). After washing and incubation with
the 3,3’,5,5’-tetramethylbenzidine (TMB) chromogenic substrates, the colored reaction product was
quantified by spectrophotometric measurement (Epoch, Biotek, Bad Friedrichshall, Germany), at a
wavelength of 450 nm.
2.3. Extracellular Oxidative Stress Evaluation
Extracellular oxidative stress level quantification was performed using two methods. In order
to assess the total superoxide dismutase (SOD) activity and the nitric oxide (NO) concentration,
ASCs were seeded in 24-well plates, at a concentration of 20 × 104 cells per well. After three days
of culture, the growth medium was replaced with a phenol-red-free medium. On the fifth day of
the experiment, the cell culture supernatants were collected and the SOD activity was determined
using a commercially available SOD Assay Kit, while NO accumulation was measured with a Griess
Reagent Kit (Life Technologies, Carlsbad, CA, USA). All assays were performed according to the
manufacturer’s protocols.
2.4. Determination of Cellular Senescence
In order to evaluate cellular senescence, the lysosomal senescence-associated β-galactosidase
enzyme (SA-β-gal) activity was determined using the Senescence Cells Histochemical Staining Kit. The
procedure was carried out in accordance to the manufacturer’s instructions. After 3 days of propagation,
the cells were fixed with the provided formaldehyde-based fixation buffer (6 min, RT), then washed with
PBS and stained with an X-gal solution containing 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside
and warmed at 37 ◦C. The incubation was carried out overnight at 37 ◦C, then the supernatants were
collected and spectrophotometrically measured (Epoch, Biotek, Bad Friedrichshall, Germany) at 450 nm.
Moreover, blue-stained senescent cells were visualized and imaged under inverted microscope.
2.5. Cell Morphology Evaluation (SEM Analysis)
Detailed cell morphology was evaluated using Scanning Electron Microscopy. To carry out the
SEM analysis, the cells were fixed with 4% paraformaldehyde (PFA), washed with distilled water, and
dehydrated in a graded ethanol series. The dehydrated samples were sprinkled with gold (ScanCoat 6,
Oxford, UK) and transferred to the microscope chamber. The observation was performed using an SE1
detector, at 10 kV of filament tension.
2.6. Fluorescent Microscopy
Visualization of the F-actin filaments was performed using Phalloidin Atto 590 staining. Cells were
fixed with 4% PFA for 45 min, at RT. Afterwards, the cells were washed with PBS and permeabilized
using 0.3% Tween 20 in PBS, for 15 min. Then, the cells were incubated with Phalloidin Atto 590 (1:800
dilution) in PBS, for 45 min, in the dark.
Mitochondria were stained using MitoRed dye. On the last day of osteogenic differentiation,
the cells were incubated with MitoRed solution (dilution 1:1000) at 37 ◦C. After 30 min of incubation,
the cells were fixed with 4% PFA and rinsed, three times, with PBS. The cells were counterstained
J. Clin. Med. 2019, 8, 765 5 of 19
with 4′,6-diamidino-2-phenylindole (DAPI), in order to visualize the cells’ nuclei. Moreover, the
mitochondrial membrane potential was determined using JC-1 staining. The cells were incubated with
JC-1 dye (1:100 dilution), for 30 min at 37 ◦C, in a CO2 incubator, rinsed with PBS, and fixed using 4%
PFA, and then counterstained with DAPI.
Cell viability was assessed using Ki-67 nuclear antigen staining. Cells were fixed with 4% PFA for
45 min at RT, washed three times with PBS and permeabilized with 0.5% Triton X-100 for 10 min, at RT.
After incubation, the cells were rinsed three times with PBS and incubated with 1% Bovine Serum
Albumin (BSA) and 22.52 mg/mL glycine solution, in Phosphate Buffered Saline with 0.2 % Tween 20
(PBST), for 30 min, to avoid unspecific binding of the antibody. Then, the cells were incubated with the
primary anti-Ki-67 antibody (dilution 1:100 in 1% BSA in PBST solution) (Abcam, Cambridge, UK),
overnight, at 4 ◦C. Thereafter, the cells were rinsed with PBS and incubated with secondary Alexa Fluor
488-conjugated anti-rabbit antibody (1:1000) (Abcam, Cambridge UK) for 1 h, at RT, in the dark. Excess
secondary antibody was washed off and the cells were counterstained with DAPI. All observations
were performed and documentation was made using a confocal microscope (Observer Z1 Confocal
Spinning Disc V.2 Zeiss with live imaging chamber). Pictures were analyzed using the ImageJ software.
2.7. Quantitative Cell Analysis Using a Flow Cytometry-Based System
Intracellular Reactive Oxygen Species (ROS) were detected using a Muse®Oxidative Stress Kit,
based on dihydroethidium (DHE). The assay allowed to distinguish two populations of cells—ROS (−)
live cells and ROS (+) cells exhibiting high content of ROS.
Changes in the mitochondrial membrane potential were evaluated using the Muse®Mitopotential
Assay Kit, which evaluated the percentage of the four cell populations—live, depolarized/live,
depolarized/dead, and dead cells.
The apoptosis rate was assessed with the Muse®Caspase-3/7 Kit and Muse®Annexin V & Dead
Cell Assay Kit. Both assays were used to determine the percentage of live, early and late apoptotic, as
well as dead cells. All procedures were performed according to the protocols provided by the supplier
and the results were acquired by means of a Muse Cell Analyzer (Merck, Darmstad, Germany).
2.8. ELISA Assay (VEGF, CXCL12/SDF-1, Adiponectin, and Leptin)
Extracellular concentrations of the Vascular Endothelial Growth Factor (VEGF), Stromal
Cell-Derived Factor 1 (SDF-1), Adiponectin, and Leptin were determined in a cell-free, conditioned,
culture medium, collected from the investigated cells. When the cells reached 85% of confluence, the
culture supernatants were replaced with a fresh medium, which was subsequently conditioned for the
next 48 h. The secreted proteins were detected using the Quantitative ELISA kits purchased from the
R&D Systems (Minneapolis, MN, USA), according to the manufacturer’s instructions.
2.9. Analysis of mRNA and microRNA Expression (RT-qPCR)
For analysis of mRNA and miRNA expression in ASCs, thrice passaged cells pellets were lysed in
TRI Reagent®Solution. In contrast, in order to obtain miRNA from MVs, the cells were cultured in a
serum-free medium for 24 h. Then, the medium was collected, centrifuged at 2000× g for 10 min at
4 ◦C, to remove cell debris, and then concentrated to 100 µL, using Amicon Ultra-15 Centrifugal Filter
(3000 MWCO, Merck, Darmstad, Germany).) via centrifugation (4000× g at 4 ◦C).
Total RNA was isolated using Chomczyński’ method [32]. Total RNA was quantified and the
260/280 nm absorbance ratios were determined using a nanospectrophotometer (Epoch, Biotek, Bad
Friedrichshall, Germany). For the mRNA analysis, gDNA was digested using DNase I, RNase-free
(Thermo ScientificTM, Waltham, MA USA), and cDNA was synthesized using a RevertAid RT Reverse
Transcription Kit (Thermo ScientificTM, Waltham, MA, USA). A total of 150 ng of the total RNA, served
as a template for a single reaction. The procedures were performed, following the protocol provided
by the producer. qRT-PCR was performed on a CFX ConnectTM Real-Time PCR Detection System
(Bio-Rad, Hercules, CA, USA). The PCRs were performed in 10-µL reaction volume, using 1 µL of
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cDNA, 500 nM of specific primers, using the SensiFast SYBR and Fluorescein Kit (Bioline, Cincinnati,
OH, USA). The sequences of the specific primers are shown in Table 1. The quantitative expression
of the investigated genes was calculated by the 2−∆∆CT method, relative to the housekeeping gene
(GAPDH).
Table 1. List of genes with accession numbers, sequences of primers, and the amplicon size of the
products in quantitative RT-PCR.
Gene Primer Sequence (Forward/Reverse) Amplicon Size (bp) Accession Number
SIRT-1
ACAGGTTGCGGGAATCCAAA/
155 NM_001314049.1
GTTCATCAGCTGGGCACCTA
HIF-1α
TTCCTTCTCTTCTCCGCGTG/
175 NM_1810542
TGGCTGCATCTCGAGACTTTT
LIN28
CCGAACCCCATGCGCACGTT/
137 XM_011542148.2
TTTGCAGGTGGCTGCGCCAAG
TGFβ GTTCTTCAATGCGTCGGAGC/ 214 NM_001081849.1
CACGACTCCGGTGACATCAA
p21 AGAAGAGGCTGGTGGCTATTT/ 169 NM_001220777.1
CCCGCCATTAGCGCATCAC
p53 AGATAGCGATGGTCTGGC/ 381 NM_001126118.1
TTGGGCAGTGCTCGCTTAGT
BAX
ACCAAGAAGCTGAGCGAGTGTC/
365 XM_011527191.1
ACAAAGATGGTCACGGTCTGCC
Cas-3
GCGGTTGTAGAAGTTAATAAAGGT/
232 NM_001354784.1
CGACATCTGTACCAGACCGAG
TERT
CGGAAGAGTGTCTGGAGCAA
107 XM_011514106.1
GGATGAAGCGGAGTCTGGA
MFN1
GTTGCCGGGTGATAGTTGGA/
270 XM_005247596.4
TGCCACCTTCATGTGTCTCC
FIS1
TGGTGCGGAGCAAGTACAAT/
251 NM_016068.2
TGCCCACGAGTCCATCTTTC
PRKN
GTGCAGAGACCGTGGAGAAA/
291 XM_017010909.2
GCTGCACTGTACCCTGAGTT
FOXO1
ATTGAGCGCTTGGACTGTGA
311 XM_014732057.1
CGCTGCCAAGTTTGACGAAA
GAPDH
GTCAGTGGTGGACCTGACCT/
256 NM_001289746.1
CACCACCCTGTTGCTGTAGC
SIRT-1—sirtuin1; HIF-1α—hypoxia inducible factor 1 alpha subunit; LIN28A—lin-28 homolog A; TGF
beta—transforming growth factor beta; p21—cyclin dependent kinase inhibitor 1A; p53—tumor suppressor p53;
BAX—Bcl-2 associated X protein; Cas-3—Caspase-3; TERT—telomerase reverse transcriptase; MFN1—mitofusin 1;
FIS1—mitochondrial fission 1 molecule; PRKN—Parkin; FOXO1—Forkhead Box O1; and GAPDH—Glyceraldehyde
3-phosphate dehydrogenase.
In order to determine the microRNA expression, 500 ng of each RNA sample was polyadenylated,
and cDNA synthesis was performed using the Mir-X miRNA First-Strand Synthesis Kit (Clontech
Laboratories, Incorporated, Mountain View, CA, USA), in accordance with the manufacturers’
instructions. The obtained cDNA was used for qRT-PCR (total volume 25 µL) with the specific
primers listed in Table 2 and SYBR Advantage qPCR Premix (Clontech Laboratories, Incorporated,
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Mountain View, CA, USA) in CFX ConnectTM Real-Time PCR Detection System (Bio-Rad, USA). The
relative miRNA expression level was calculated using the 2−∆∆CT algorithm, in relation to U6 snRNA,
used as an endogenous control.
Table 2. Sequences of the primers used in the qPCR for the miRNA expression analysis.
Gene Primer Sequence (5′→3′) Accession Number
miR-24-3p TGGCTCAGTTCAGCAGGAACAG MIMAT0000080
miR-17-5p CAAAGTGCTTACAGTGCAGGTAG MIMAT0000070
miR-16-5p TAGCAGCACGTAAATATTGGCG MIMAT0000069
miR-140-3p TACCACAGGGTAGAACCACGGA MIMAT0004597
miR-146a-5p TGAGAACTGAATTCCATGGGTT MIMAT0000449
miR-145-5p GTCCAGTTTTCCCAGGAATCCCT MIMAT0000437
2.10. Statistical Analysis
Statistical analysis was performed using unpaired Student’s t-test with the GraphPad Prism 5
software (San Diego, CA, USA). In the study, we compared the non-diabetic (n = 6) and diabetic
patient (n = 6) groups. Asterisk (*) indicated statistical significance between the two groups. A p value
less than 0.05 (p < 0.05) was summarized with one asterisk (*), one less than 0.01 (p < 0.01) with two
asterisks (**), and one less than 0.001 (p < 0.001) with three asterisks (***).
3. Results and Discussion
3.1. Type 2 Diabetes Diminishes ASC Proliferation and Increases Apoptosis
ASCs exhibited an extensive capacity for proliferation, self-renewal, and showed the potential
to differentiate into insulin—producing cells, which make them a good candidate for cell therapy
applications in many pathologies, including type 2 diabetes. Therefore, it was not surprising
that extensive studies were necessary to derive which type of ASC transplantation would be the
best—autologous or allogenic. Numerous studies have reported that ASC stemness can be diminished
by the ageing of donors or metabolic disorders, including insulin resistance, hyperglycemia, and lipid
accumulation, leading to T2D. To compare the cellular proliferation of ASCs derived from diabetic and
non-diabetic patients, we performed Ki-67 expression analysis, using immunofluorescence staining,
PDT calculation, and BrdU Cell Proliferation Assay. Ki-67 is a nuclear protein highly associated with
cell proliferation, and is expressed in the G1, S, G2, and M cell cycle phases, but is not present in the G0
phase. The Ki-67 percentage score was acquired as the percentage of positively-stained cells, among the
total number of ASC cells assessed [33,34]. We noted that, ASCCTRL displayed a higher expression of
Ki-67 (p < 0.05). More than 60% of the control cells were Ki-67-positive, while the percentage of ASCT2D
expressing Ki-67 was approximately 40% (Figure 1A). Differences in the proliferation rate of ASCs
from the CTRL and T2D groups were observed in the in vitro culture, using resazurin-based TOX-8
assay (Figure 1B)—to estimate the PDT—and the BrdU Cell Proliferation Assay Kit (Figure 1C). ASCs
derived from the non-diabetic donors had a significantly shorter population double-time, compared
to the ASCT2D (p < 0.05) (Figure 1B). BrdU assay detected the incorporated 5-bromo-2′deoxyuridine
(BrdU) (pyrimidine analog), in the newly synthesized DNA of the proliferating cells. We observed
a two-fold lower content of the incorporated BrdU, in the DNA of ASCs from diabetic patients
(p < 0.001) (Figure 1C). The decreased Ki-67 expression, significantly higher PDT, and lower content of
incorporated BrdU in DNA, indicated a reduced ASCT2D proliferation activity. Similarly, many recent
studies on the animal models have demonstrated that several factors, such as aging and metabolic
diseases, strongly affect ASCs proliferation [29,35,36]. Moreover, it has been demonstrated that reduced
proliferation activity was closely related to telomere length shortening in patients with age-related
diseases and type 2 diabetes [26,37].
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was showed as Ki-67 positive cells percentage. Scale bar: 50 µm. (b) population doubling-time (PDT) 
value was determined using TOX-8 Resazurin-based Assay. (c) BrdU incorporation assay. Cells were 
cultured with BrdU labeling medium for 18 h. (d) Transcript levels of the apoptosis-related genes 
was determined using the qRT-PCR method. The black dotted line indicated the transcript levels of 
genes in the ASCCTRL group. (e,f) Evaluation of apoptosis and cell death using the Muse Cell 
Analyzer. The percentage of live, apoptotic, apoptotic/dead, and dead cell was assessed using thee 
Annexin/7AAD and Caspase-3/7 tests. Results are expressed as mean ± SD. Statistical significance is 
indicated by asterisks (*); * p < 0.05, ** p < 0.01, *** p < 0.001, as examined by unpaired Student’s t-test. 
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(ASCT2D) (n = 6). (a) Representative images of i unofl resce ce stai i f r i-67 ( ree ). Nuclei
were counterstained with 4′,6-diamidino-2-phenylindole (D PI) (bl e). i-67 ex ression in SCs
was showed as Ki-67 positive cells percentage. Scale bar: 50 µ . (b) population doubling-time (PDT)
value was determined using TOX-8 Resazurin-based Assay. (c) BrdU incorporation assay. Cells were
cultured with BrdU labeling medium for 18 h. (d) Transcript levels of the apoptosis-related genes was
determined using the qRT-PCR method. The black dotted line indicated the transcript levels of genes
in the ASCCTRL group. (e,f) Evaluation of apoptosis and cell death using the Muse Cell Analyzer. The
percentage of live, apoptotic, apoptotic/dead, and dead cell was assessed using thee Annexin/7AAD
and Caspase-3/7 tests. Results are expressed as mean ± SD. Statistical significance is indicated by
asterisks (*); * p < 0.05, ** p < 0.01, *** p < 0.001, as examined by unpaired Student’s t-test.
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Cell apoptosis was estimated by quantitative polymerase chain reaction and Muse Cell Analyzer.
Thus, we compared the basal transcript levels of the genes encoding the proteins related to apoptosis
(p21, p53, BAX, Cas-3) in ASCs derived from diabetic and non-diabetic patients. Overall, p21, p53,
and BAX expression was higher in the T2D group. Moreover, we noted an overexpression of Cas-3
(p < 0.001) in the ASCs from diabetic donors (Figure 1D). Annexin V and Dead Cell analysis allowed
for the quantitative analysis of live (Annexin V (−) and 7AAD (−)), early apoptotic (Annexin V (+)
and 7AAD (−)), late apoptotic (Annexin V (+) and 7AAD (+)), and necrotic cells (Annexin V (−) and
7AAD (+)). We observed a significantly higher content of living cells in the T2D group (p > 0.001),
whereas fewer cells from the T2D group exhibited an early apoptotic stage (p > 0.01). Interestingly,
there were more late apoptotic and dead cells in the T2D group (Figure 1E). Further examination of
cellular apoptosis by the Muse Cell Analyzer showed a significantly lower content of live cells in the
ASC population derived from diabetic donors (p > 0.001), and a greater percentage of apoptotic/dead
cells (p > 0.001) (Figure 1F). The obtained results correlated with our previous study on animal model,
which showed that the metabolic syndrome enhanced the apoptosis in ASCs [12,29,35].
3.2. Cellular Senescence and Extracellular Oxidative Stress in ASCs are Associated with Type 2 Diabetes
Senescent cells are characterized by an increased activity of senescence-associated β-galactosidase
(SA β-gal) [38]. Using the SA β-gal assay (SA β-gal positive blue-green stained cells), we compared
cellular senescence in ASCs derived from non-diabetic and diabetic patients. We observed an increased
percentage of SA β-gal positive cells in ASCT2D (black arrows). The result was confirmed by the
spectrophotometric measurement; the dye absorption was significantly higher in the ASCs derived
from the diabetic patients (p < 0.05) (Figure 2A). Moreover, we observed a significant downregulation
of the telomerase reverse transcriptase (TERT) in ASCT2D (p < 0.001) (Figure 2E). Telomerase, a complex
of the reverse transcriptase protein and a template RNA TERC (telomerase RNA component) is
responsible for the synthesis of telomeric repeats onto the chromosomes ends. The mechanism protects
cells from the replication-dependent loss of telomere, which leads to cellular senescence in highly
proliferative cells, such as ASCs [39]. It has been previously reported that, telomerase shortening
induces cellular senescence and apoptosis, and is highly associated with the TERT activity [40]. Its
downregulation leads to telomere shortening, resulting in cellular senescence and apoptosis.
Morphological alterations were evaluated using SEM imaging (Figure 2B), f-actin, and nuclei
staining (Figure 2D). ASCs derived from the non-diabetic patients exhibited uniform and bipolar
fibroblastic-like phenotype, whereas a great majority of ASCT2D were rather flat, and had irregular
cells with enlarged nuclei. Moreover, determination of nuclear size, using SEM, revealed that the
nuclei of ASCs derived from the T2D-patients group, showed a greater diameter than the control group
(p < 0.05) (Figure 2B). According to several studies, the enlarged cell nuclei is a biomarker of cellular
senescence [41,42]. Interestingly, the phalloidin and DAPI staining showed that, both, the smaller
ASCCTRL and the larger ASCT2D, exhibited a well-developed cytoskeleton (Figure 2D). Our data were
partially consistent with our previous study, in which we demonstrated a similar morphology of ASCs
derived from horses suffering from equine metabolic syndrome (EMS) [29]. The obtained results
indicated that ASCs derived from type 2 diabetes donors exhibited a phenotype of senescent cells.
Cellular senescence can be induced by various factors, including oxidative stress [43]. SOD
enzymes control the levels of NO and ROS, thus, protecting the cells from potential damage caused by
excessive ROS. In order to assess the extracellular oxidative stress, SOD and NO assays were performed
using cells-free supernatants collected from ASCs, after five days of culture. We observed a significantly
lower total SOD activity in the T2D group, represented by the percentage of inhibition (p < 0.001) and
a higher concentration of NO (p < 0.01) (Figure 2C). Excessive release of NO, and inhibition of the SOD
activity indicated an elevated oxidative stress level in ASCs derived from diabetic donors. Our research
stayed in a good agreement with the findings observed in both human and animal models [28,44,45].
As reported by Lee et al., the oxidative stress in adipose tissue can cause an increase in preadipocyte
proliferation, adipogenesis, and the size of mature adipocytes, and therefore, increases fat mass [46].
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3.3. Comparison of the Mitochondrial Dynamics and Mitochondrial Membrane Potential
Mitochondria are extremely dynamic organelles, undergoing frequented cycles of fusion and
fission, which serve to regulate mitochondrial functioning, by enabling their transient and rapid
adaptations to the metabolic requirements of cells [47]. To assess the mitochondrial dynamics in ASCs
derived from a diabetic donor, we performed mitochondria staining with MitoRed (Figure 3A) and
quantitative real-time PCR (Figure 3B). Mitochondria in the ASCs from control group, exhibited a typical
tubular structure, which formed a robust mitochondria network. By contrast, the ASCT2D contained
round mitochondria characterized by a fragmented phenotype (Figure 3A). Mitochondrial network
fragmentation indicated diminishing fusion or escalating fission, which was confirmed by qRT-PCR.
Overexpression of FIS1 in ASC derived from diabetic donors, led to mitochondria fragmentation
(p > 0.01), whereas, the transcript level of MFN1 responsible for the regulation of mitochondrial fusion
was significantly decreased in these cells (p > 0.01). Overexpression of FIS1 led to an increase of the
FIS1/MFN1 ratio (p > 0.01). Moreover, PRKN (mitophagy stimulator) expression was significantly
reduced in ASCT2D (p > 0.01) (Figure 3B). Taken together, these results indicated that fission appeared
to be predominant over fusion, in these cells. Moreover, downregulation of PRKN expression is
known to impair mitophagy, which is crucial for the clearance of damaged mitochondria. This effect
was consistent with our previous studies, where we observed an increased mitochondrial fission
in ASC derived from EMS horses [28,35,45]. Moreover, we have demonstrated that mitochondrial
fragmentation is linked to an increased release of NO and impaired SOD activity in ASCT2D. These
results showed that the metabolic disorders affected the mitochondrial network and probably induced
their dysfunction on its own, not only by enhancing mitochondrial fission but also by impairing
mitochondrial autophagy. As is well-known, dysfunctional mitochondria are the main source of ROS,
therefore, the removal of damaged mitochondria via mitophagy is important for the maintenance
of oxygen homeostasis, by a lower ROS generation. Experimental studies have previously shown
that under normal conditions, fission is a process that separates damaged mitochondria from the
network, and permits their removal, through mitophagy [48], which is impaired during the metabolic
syndrome. Furthermore, present results stay in good agreement with our previous findings [29], as
well as the results of Wang et al. [49], which showed that mitochondria impairment is highly associated
with apoptosis, which is preceded by mitochondrial depolarization. JC-1 staining is widely used to
monitor mitochondrial health in a variety of cell types. Thus, mitochondria depolarization is indicated
by a decrease in red (~590 nm)/green (~529 nm) fluorescence intensity ratio. ASCT2D exhibited no
alternation in JC-1 green/red fluorescence intensity (Figure 3C). MitoPotential test using the Muse Cell
Analyzer revealed higher levels of dead cells in the T2D group, whereas, there were no significant
differences in mitochondrial membrane depolarization between the tested groups (Figure 3D). These
results suggest that metabolic alternations led to mitochondrial dysfunction, and consequently, induced
cell death via apoptosis.
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3.4. Expression of mRNA and miRNA Associated with Cell Proliferation and Insulin Resistance
In order to evaluate, both, the mRNA and miRNA expression patterns of the selected genes and the
miRNA involved in cellular proliferation, the regulation of glucose homeostasis, and insulin sensitivity,
qRT-PCR was performed. We observed that the expression level of genes involved in the control
of the glucose–lipid metabolism, namely, SIRT-1, LIN28, and FOXO1 were highly downregulated
in ASCs derived from diabetic patients (p < 0.01, p < 0.001, and p < 0.01, respectively). Similarly,
TGFβ and HIF-1α transcript levels appeared to be significantly higher in the control group (p < 0.001)
(Figure 4A). Several reports have shown that SIRT-1 is an important regulator of glucose metabolism,
insulin sensitivity [50], and ASC differentiation towards osteoblasts and chondrocytes, in vitro [51].
Our result was in a good agreement with several animal studies that have provided strong evidence
on the positive effect of decreased SIRT-1 activity, on the development of T2D-related conditions,
including insulin resistance and obesity. Furthermore, SIRT-1 was a crucial regulator of FOXO-mediated
transcription, during the development of insulin resistance [51]. A growing body of evidence indicates
a dual role of HIF-1α, in insulin resistance. Overexpression of HIF-1α promotes cell survival via
repression of p53, phosphorylated-p53, and p21, under normoxia [52], on the other hand, inhibition
of HIF-1α activity improves insulin sensitivity [53]. Our results suggest that metabolic disorders
diminish cell viability and increase cell apoptosis, through downregulation of HIF-1α. As expected,
the expression of Lin28 was significantly reduced in ASCT2D, suggesting that these cells lost their
self-renewal abilities, at least partially, whereas a diminished expression of TGFβ might indicate
impaired immunomodulatory properties.
The miRNA expression was analyzed for the following miRNAs: miR-16-5p, 17-5p, 24-3p, 145-5p,
140-3p, and miR-146. ASCs derived from diabetic donors were characterized by increased expression
of miRNA involved in cell proliferation, such as miR-16-5p miR-146a-5p and miR-145-5p (p < 0.001),
which when overexpressed, suppressed proliferation [54]. Furthermore, some of the studied miRNAs
played crucial roles in the glucose and lipid metabolism, like miR-24-3p (p < 0.001), which mainly
contributed to the increase of glucose uptake [55] and miR-17-5p, whose expression was highly reduced
in ASCT2D (p < 0.05), this strongly correlated with the findings revealed by Dong et al., who showed
that miR-17 expression was downregulated, in a high glucose condition [56]. Moreover, we observed
an upregulation of miR-140-3p, which was highly linked to T2D (p < 0.001) (Figure 4B). These results
indicated that type 2 diabetes significantly altered, both, the mRNA and miRNA expression profiles of
ASC, thus, reducing their viability, proliferation activity, glucose homeostasis, and insulin sensitivity.
3.5. Alternations in Selected miRNA and Protein Levels in ASCs Derived from T2D Patients Exhibit their
Impairment of Proliferation Activity, Regenerative Potential, and Insulin Sensitivity
The use of ASCs in regenerative medicine included cell-free therapies such as application of
secretome, besides the stem cell transplantation. ASCs produce and secrete a wide array of chemokines,
growth factors, and extracellular vesicles containing mRNA and miRNA. ASC secretome can prevent
cell apoptosis, and promote endogenous repair mechanisms and angiogenesis. To evaluate and
compare the concentration of VEGF, CXCL12, leptin, and total adiponectin/acrp30 in conditioned media
collected from ASCCTRL and ASCT2D, ELISA assays were performed. In the ASCCTRL culture medium,
we detected a significant higher concentration of VEGF (p > 0.01), that mediated the differentiation of
endothelial progenitor cells and induced corneal neovascularization, in vivo [57]. It is well-documented
that VEGF level is decreased in type 2 diabetic patients sera, which is directly linked to the impairment
of angiogenesis in diabetic conditions [12,57]. Moreover, we observed a downregulation of CXCL12
(also named stromal cell-derived factor-1, SDF-1) (p < 0.05) and adiponectin (p < 0.01), whereas
an overexpression of leptin (p < 0.001) significantly reduced the adiponectin/leptin ratio (p < 0.01)
(Figure 5A). CXCL12 plays a role in diverse cellular functions, including response to inflammation
and maintaining the stemness of hematopoietic stem cells (HSCs). Hu et al. previously reported
that CXCL12 accelerated the epithelialization of burn wound through MSC mobilization [58]. Our
result was consistent with the findings of Kočí et al. who showed that ASCT2D were typically prone
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to downregulated CXCL12 [59]. Leptin and adiponectin had opposite effects on insulin resistance
and chronic inflammation. Leptin upregulated pro-inflammatory cytokines, whereas adiponectin
exhibited anti-inflammatory properties. The observed adiponectin/leptin imbalance suggested that
ASCs derived from diabetic patients exhibit impaired immunomodulatory properties.
Extracellular vesicles, including MVs and exosomes were extracted with an ultracel centrifugal
filter device, with a 3 kDa molecular weight cut-off (MWCO). Isolated EVs were subsequently subjected
to an extracellular miRNAs level analysis, using qRT-PCR. Interestingly, we observed a similar
correlation between the intracellular and extracellular miRNAs expression (Figure 5B), suggesting
that the expression level of the circulating miRNAs, probably represented a balance between miRNA
release and uptake.
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Figure 5. Comparison of selected miRNAs and proteins secreted by adipose-derived mesenchymal
stem cells, isolated from non-diabetic (n = 6) individuals and patients suffering from type 2 diabetes
(T2D) (n = 6). (a) Proteome analysis of the conditioned media from the ASCCTRL and the ASCT2D
was performed using the ELISA method. (b) miRNA levels in extracellular vesicles extracted using
Amicon Ultra 15 filter (3000 MWCO). Extracellular miRNA expression profiling was determined using
quantitative PCR. Results expressed as mean ± SD. Statistical significance indicated as asterisk (*):
* p < 0.05, ** p < 0.01, and *** p < 0.001 were examined through unpaired Student’s t-test.
4. Conclusions
ASCs are considered to be a highly attractive therapeutic strategy, whereas, their physiological
deterioration in the diabetic condition, limits their use in autologous transplantation. The obtained
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results confirmed that type 2 diabetes impairs critical functions of ASCs, such as viability, proliferation
activity, mitochondrial dynamics, protective mechanisms against oxidative stress, as well as secretory
capacity. Moreover, our findings suggest that metabolic disorders lead to an impaired glucose
homeostasis and insulin sensitivity, through the downregulation of several mRNA and miRNA, which
play an important role in glucose and lipid metabolism. Thus, it seems that before any clinical
applications of ASCs derived from diabetic patient can be implemented, their pharmacological ex vivo
improvement is strongly required.
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